Pentetic Acid

Pentetic Acid

SCHEMBL16245517

O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O.[NaH].[NaH].[NaH].[Zn]

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.88
▸ BLM P54132 2/20 0.88
▸ PMP22 Q01453 2/20 0.88
▸ KDM4E B2RXH2 2/20 0.88
▸ ALOX15 P16050 2/20 0.88
▸ LMNA P02545 1/20 0.88
▸ CHRM2 P08172 1/20 0.88
▸ ADRA2A P08913 1/20 0.88
▸ TSHR P16473 1/20 0.88
▸ DRD1 P21728 1/20 0.88
▸ SLC6A2 P23975 1/20 0.88
▸ SLC6A4 P31645 1/20 0.88
▸ CYP2C19 P33261 1/20 0.88
▸ ADRA1A P35348 1/20 0.88
▸ DRD3 P35462 1/20 0.88
▸ SLC6A3 Q01959 1/20 0.88
▸ HRH3 Q9Y5N1 1/20 0.88
▸ EYA2 O00167 1/20 0.82
▸ APP P05067 1/20 0.82
▸ ACE P12821 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edetic Acid SCHEMBL28876396 0.97 TDP1 (0.88) TDP1BLMPMP22KDM4EALOX15
Edetic Acid SCHEMBL4956650 0.97 TDP1 (0.88) TDP1BLMPMP22KDM4EALOX15
Edetic Acid SCHEMBL1091249 0.97 TDP1 (0.88) TDP1BLMPMP22KDM4EALOX15
Edetic Acid SCHEMBL8376356 0.97 TDP1 (0.88) TDP1BLMPMP22KDM4EALOX15
Edetic Acid SCHEMBL4637550 0.97 TDP1 (0.88) TDP1BLMPMP22KDM4EALOX15
Pentetic Acid SCHEMBL456025 0.97 TDP1 (0.94) TDP1BLMPMP22KDM4EALOX15
Pentetic Acid SCHEMBL18917020 0.94 TDP1 (0.88) TDP1BLMPMP22KDM4EALOX15
Pentetic Acid SCHEMBL10888673 0.94 TDP1 (0.88) TDP1BLMPMP22KDM4EALOX15
Pentetic Acid SCHEMBL1436141 0.94 TDP1 (0.88) TDP1BLMPMP22KDM4EALOX15
Pentetic Acid SCHEMBL2819134 0.94 TDP1 (0.88) TDP1BLMPMP22KDM4EALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9447120-B2 Crystalline forms of zinc trisodium pentetic acid HAMELN PHARMA PLUS GMBH (DE) 2016-09-20 — — US disclosed
US-9447120-B2 Crystalline forms of zinc trisodium pentetic acid HAMELN PHARMA PLUS GMBH (DE) 2016-09-20 — — US disclosed
US-20160130283-A1 CRYSTALLINE FORMS OF ZINC TRISODIUM PENTETIC ACID HAMELN PHARMA PLUS GMBH (DE) 2016-05-12 — — US disclosed
US-20160130283-A1 CRYSTALLINE FORMS OF ZINC TRISODIUM PENTETIC ACID HAMELN PHARMA PLUS GMBH (DE) 2016-05-12 — — US disclosed
EP-2999706-A1 CRYSTALLINE FORMS OF ZINC TRISODIUM PENTETIC ACID hameln pharma plus gmbh (DE) 2016-03-30 — — EP disclosed
EP-2999706-A1 CRYSTALLINE FORMS OF ZINC TRISODIUM PENTETIC ACID hameln pharma plus gmbh (DE) 2016-03-30 — — EP disclosed
WO-2014187930-A1 CRYSTALLINE FORMS OF ZINC TRISODIUM PENTETIC ACID HAMELN RDS GMBH (DE) 2014-11-27 — — WO disclosed
WO-2014187930-A1 CRYSTALLINE FORMS OF ZINC TRISODIUM PENTETIC ACID HAMELN RDS GMBH (DE) 2014-11-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130283-A1 CRYSTALLINE FORMS OF ZINC TRISODIUM PENTETIC ACID SLC39A11, SLC30A6, SLC39A3 TDP1 3957/4885BLM 1416/4885PMP22 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback